← Eichor
Study identifier: NCT07228377 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study

Condition: Cancer  ·  Sponsor: Medstar Health Research Institute

PhaseNA
Planned participants25
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients living with cancer commonly have chronic pain due to the disease or to cancer treatments. Virtual reality, a new technology that immerses the user in pleasant, diverting, and exciting virtual environments, may lower chronic cancer pain to improve quality of life and complement need for pain medications like opioids. The investigators aim to learn from patients about the experience of cancer pain, develop a virtual reality prototype specific to cancer pain management, and test the feasibility and acceptability of this technology to improve the cancer pain experience.

This description comes directly from the study's public registry record.

Talk to the study team

Hunter Groninger, MD  ·  202-877-7445  ·  hunter.groninger@medstar.net

Eloisa Leiva  ·  eloisa.leiva@medstar.net

Always discuss trial participation with your own doctor first.

Locations (1)

MedStar Georgetown Cancer Institute at MedStar Washington Hospital CenterWashington D.C., District of Columbia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07228377